Topic: Eli Lilly and Company

Olanzapine

acute and maintenance treatment of Schizophrenia in adults, acute treatment of manic or mixed episodes associated with Bipolar I Disorder (monotherapy and in combination with lithium or valproate ) intramuscular formulation: There is no specific, known antidote for olanzapine overdose, and even ...
A new study is likely to add to the furious debate over the rapid rise in the prescription of heavy-duty antipsychotic drugs to children. Seroquel from AstraZeneca ( AZN - news - people ), Risperdal from Johnson & Johnson ( JNJ - ...
Eli Lilly has received approval from the U.S. Food and Drug Administration for use of a combo pill called Symbyax to treat treatment-resistant depression.. Symbyax, which combines the active ingredients of its Zyprexa antipsychotic and Prozac antidepressant, is approved for patients with ...

No Blues For Eli Lilly

On Monday, Eli Lilly announced that the U.S. Food and Drug Administration expanded its approval of Symbyax, making it the first drug accepted to combat this type of depression.. Symbyax, which combines the active ingredients of its Zyprexa antipsychotic and Prozac antidepressant, ...
US drugmaker Eli Lilly pleaded guilty to violating US law in its marketing of anti-psychotic drug Zyprexa and will pay 1.42 billion dollars to settle criminal and civil allegations, officials said Thursday.Eli Lilly said it had entered a misdemeanor plea for violation ...

Eli Lilly To Pay $62M To N.C. And 31 Other States

RALEIGH, N.C. - Eli Lilly and Company, a major pharmaceutical manufacturer, has agreed to pay a record $62 million to North Carolina and 31 other states to resolve allegations that the company improperly marketed the antipsychotic drug Zyprexa, officials said Tuesday. Cooper ...